1-5 of 5
Dan Zhao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venetoclax Combined with Hag Regimen in Newly Diagnosed ETP-ALL: A Prospective, Multicenter, Phase 2 Trial

Shanshan Suo, Ying Lu, Wenjuan Yu, Chunmei Yang, Lijing Shen, Renzhi Pei, Beiwen Ni, Wanzhuo Xie, Liping Mao, Xingnong Ye, Jiejing Qian, Jin Wang, Bingzong Li, Xiaomin Wang, Linjie Li, Dan Zhao, Yongming Xia, Lihong Shou, Yanping Shao, Da Gao, Wenyuan Mai, De Zhou, Gaixiang Xu, Min Yang, Yinjun Lou, Hongyan Tong, Huafeng Wang, Jie Jin
Journal: Blood
Blood (2024) 144 (Supplement 1): 836.
https://doi.org/10.1182/blood-2024-208355
Published: 2024
Journal Articles

Venetoclax Combined with Hag Regimen in Newly Diagnosed ETP-ALL: Interim Analysis of a Prospective, Multicenter, Phase 2 Trial

Shanshan Suo, Wen-Juan Yu, Ying Lu, Jiejing Qian, Liping Mao, Jin Wang, Lijing Shen, Bingzong Li, Huafeng Wang, Wenyuan MAI, Wanzhuo Xie, Xiaomin Wang, Dan Zhao, Yuanfang Liu, Chuan He, Jie Jin
Journal: Blood
Blood (2023) 142 (Supplement 1): 2869.
https://doi.org/10.1182/blood-2023-191190
Published: 2023
Journal Articles

A Randomized Phase 2 Study of Pevonedistat, Venetoclax, and Azacitidine Versus Venetoclax Plus Azacitidine in Adults with Newly Diagnosed Acute Myeloid Leukemia (AML) Who Are Unfit for Intensive Chemotherapy

Nicholas J. Short, MD, Farhad Sedarati, Dan Zhao, Olga Tsukurov, Sharon Friedlander, Douglas V. Faller
Journal: Blood
Blood (2020) 136 (Supplement 1): 34–35.
https://doi.org/10.1182/blood-2020-136968
Published: 2020
Journal Articles

DNA Methylation Analysis before and during Treatment with Azacitidine Plus Pevonedistat or Azacitidine Alone in Patients with MDS, CMML, and AML Previously Untreated with Hypomethylating Agents

Soo Park, MD, Brian M Reilly, BS, Timothy Luger, Dan Zhao, Robert J. Fram, MD, Ajeeta B Dash, PhD, Rafael Bejar, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-134484
Published: 2020
Journal Articles

ONC201 Depletes Cancer Stem Cells in Refractory Cancer Patient Samples

Varun Vijay Prabhu, Jo Ishizawa, MD PhD, Dan Zhao, MD PhD, Joshua E. Allen, PhD, Tracy T. Batchelor, MD, Andrew S. Chi, MD PhD, Michael Andreeff, MD PhD, Wafik S. El-Deiry, MD PhD F.A.C.P
Journal: Blood
Blood (2014) 124 (21): 5219.
https://doi.org/10.1182/blood.V124.21.5219.5219
Published: 2014